SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-029749
Filing Date
2013-05-30
Accepted
2013-05-30 19:22:58
Documents
1
Period of Report
2013-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4508
  Complete submission text file 0001209191-13-029749.txt   6631
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2882 SAND HILL ROAD, SUITE 121 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD, SUITE 121 MENLO PARK CA 94025 650-926-0734
Astellas Venture Fund I L.P. (Reporting) CIK: 0001576141 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-35945 | Film No.: 13883206

Mailing Address 2882 SAND HILL ROAD, SUITE 121 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD, SUITE 121 MENLO PARK CA 94025 650-926-0734
Astellas Venture Management LLC (Reporting) CIK: 0001577630 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-35945 | Film No.: 13883207